This website uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Statement for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time. I accept / More info
For more information on which cookies we use then please refer to our Cookie Policy.
Setting up the KWM International Center is a significant strategic deployment for the firm.
King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating...
Analysis of the 2018-19 Australian Federal Budget: significant reforms for corporates, small business and personal tax.
King & Wood Mallesons (KWM) was the biggest winner with 12 awards at the Thomson Reuters ALB China Law Awards 2018 held in Beijing.
We explore how international arbitration has adapted and will continue to adapt in 2018 to global challenges and opportunities.
This article covers some helpful tips on Hong Kong’s merger control regime.
KWM advised the sole sponsor and underwriters on the IPO of Dowway Holdings on GEM of The Stock Exchange of Hong Kong by way of share offer.
China's SAFE recently made several enhancements to an existing pilot program regarding the cross-border transfer of Chinese NPLs to foreign investors.
With penalties escalating and a heightened regulatory focus on effective financial crime compliance, we are delighted to share with you the chapters that KWM has written for The ICLG.